tickertape
← runs

BMY

BRISTOL MYERS SQUIBB COeval run
10-K for period ending 2025-12-31gpt-6-luna@none · prompt v4$0.00073.5sfiling on sec.gov ↗

figures

fieldvaluestatement rowprintedSEC
Total revenue$48.2BR4 Total Revenues48,194 millions$48.2B ✓
Operating income-not printed on this statement--
Net income attributable to the company$7.1BR16 Net earnings/(loss) attributable to BMS7,054 millions$7.1B ✓
Diluted EPS$3.46R19 Diluted3.46$3.46 ✓
Cash and cash equivalents$10.2BR3 Cash and cash equivalents10,209 millions$10.2B ✓
Total assets$90.0BR15 Total Assets90,038 millions$90.0B ✓
Total liabilities$71.5BR25 Total Liabilities71,533 millions$71.5B ✓
Total shareholders' equity attributable to the company$18.5BR35 Total BMS Shareholders’ Equity18,473 millions$18.5B ✓
Net cash from operating activities$14.2BR21 Net cash provided by operating activities14,156 millions$14.2B ✓
Net cash from investing activities-$4.1BR29 Net cash provided by/(used in) investing activities(4,132) millions-$4.1B ✓
Net cash from financing activities-$10.3BR39 Net cash provided by/(used in) financing activities(10,348) millions-$10.3B ✓

checks

  • assets = liabilities + equity · total assets equals total liabilities and equity
  • equity excludes minority interests · totalEquity excludes noncontrolling interests
  • net income is before preferred dividends · net income is not the after-preferred-dividends line
  • diluted EPS is for total net income · diluted EPS is for total net income
  • net income excludes minority interests · netIncome excludes noncontrolling interests
  • cash flows tie to the change in cash · not applicable: missing a section total or no net change in cash line

management's claims

No year-over-year claims about the headline figures were found in management's discussion.

trace

  1. 0locator (code)0.20s
    {
  "tables": 177,
  "exhibits": [],
  "documents": 1
}
    {
  "income": {
    "rows": 20,
    "scale": 1000000,
    "score": 49.5,
    "heading": "ENTARY DATA. BRISTOL-MYERS SQUIBB COMPANY CONSOLIDATED STATEMENTS OF EARNINGS Dollars in millions, except per share data",
    "tableIndex": 82,
    "runnerUpScore": 22.5
  },
  "balance": {
    "rows": 39,
    "scale": 1000000,
    "score": 52.75,
    "heading": "ements. 73 BRISTOL-MYERS SQUIBB COMPANY CONSOLIDATED BALANCE SHEETS Dollars in millions, except share and per share data",
    "tableIndex": 84,
    "runnerUpScore": 21
  },
  "cashflow": {
    "rows": 44,
    "scale": 1000000,
    "score": 54.5,
    "heading": "olidated financial statements. 74 BRISTOL-MYERS SQUIBB COMPANY CONSOLIDATED STATEMENTS OF CASH FLOWS Dollars in millions",
    "tableIndex": 85,
    "runnerUpScore": 10
  }
}
  2. 1cash flow agent1.78s · 1589 tokens · $0.0002
    {
  "rows": 44,
  "retryHint": null,
  "tableIndex": 85
}
    {
  "figures": [
    {
      "note": "This is the operating activities section total after changes in operating assets and liabilities.",
      "field": "operatingCashFlow",
      "scale": 1000000,
      "value": 14156000000,
      "printed": "14,156",
      "rowIndex": 21,
      "rowLabel": "Net cash provided by operating activities",
      "priorValue": 15190000000,
      "agentPrinted": "14,156",
      "failedChecks": [],
      "priorPrinted": "15,190",
      "groundingMismatch": false
    },
    {
      "note": "This is the net investing activities section total.",
      "field": "investingCashFlow",
      "scale": 1000000,
      "value": -4132000000,
      "printed": "(4,132)",
      "rowIndex": 29,
      "rowLabel": "Net cash provided by/(used in) investing activities",
      "priorValue": -21352000000,
      "agentPrinted": "(4,132)",
      "failedChecks": [],
      "priorPrinted": "(21,352)",
      "groundingMismatch": false
    },
    {
      "note": "This is the net financing activities section total.",
      "field": "financingCashFlow",
      "scale": 1000000,
      "value": -10348000000,
      "printed": "(10,348)",
      "rowIndex": 39,
      "rowLabel": "Net cash provided by/(used in) financing activities",
      "priorValue": 5127000000,
      "agentPrinted": "(10,348)",
      "failedChecks": [],
      "priorPrinted": "5,127",
      "groundingMismatch": false
    }
  ],
  "statement": "cashflow",
  "tableIndex": 85,
  "priorColumn": 1,
  "currentColumn": 0
}
  3. 2income statement agent1.78s · 1395 tokens · $0.0002
    {
  "rows": 20,
  "retryHint": null,
  "tableIndex": 82
}
    {
  "figures": [
    {
      "note": "Total Revenues is the company-wide revenue total.",
      "field": "revenue",
      "scale": 1000000,
      "value": 48194000000,
      "printed": "48,194",
      "rowIndex": 4,
      "rowLabel": "Total Revenues",
      "priorValue": 48300000000,
      "agentPrinted": "48,194",
      "failedChecks": [],
      "priorPrinted": "48,300",
      "groundingMismatch": false
    },
    {
      "note": "The statement does not print an operating income line.",
      "field": "operatingIncome",
      "scale": 1000000,
      "value": null,
      "printed": null,
      "rowIndex": null,
      "rowLabel": null,
      "priorValue": null,
      "agentPrinted": null,
      "failedChecks": [],
      "priorPrinted": null,
      "groundingMismatch": false
    },
    {
      "note": "This is net earnings attributable to BMS, excluding noncontrolling interest.",
      "field": "netIncome",
      "scale": 1000000,
      "value": 7054000000,
      "printed": "7,054",
      "rowIndex": 16,
      "rowLabel": "Net earnings/(loss) attributable to BMS",
      "priorValue": -8948000000,
      "agentPrinted": "7,054",
      "failedChecks": [],
      "priorPrinted": "(8,948)",
      "groundingMismatch": false
    },
    {
      "note": "This is the diluted earnings per common share figure.",
      "field": "epsDiluted",
      "scale": 1,
      "value": 3.46,
      "printed": "3.46",
      "rowIndex": 19,
      "rowLabel": "Diluted",
      "priorValue": -4.41,
      "agentPrinted": "3.46",
      "failedChecks": [],
      "priorPrinted": "(4.41)",
      "groundingMismatch": false
    }
  ],
  "statement": "income",
  "tableIndex": 82,
  "priorColumn": 1,
  "currentColumn": 0
}
  4. 3balance sheet agent1.92s · 1444 tokens · $0.0002
    {
  "rows": 39,
  "retryHint": null,
  "tableIndex": 84
}
    {
  "figures": [
    {
      "note": "This is the balance-sheet cash and cash equivalents line.",
      "field": "cash",
      "scale": 1000000,
      "value": 10209000000,
      "printed": "10,209",
      "rowIndex": 3,
      "rowLabel": "Cash and cash equivalents",
      "priorValue": 10346000000,
      "agentPrinted": "10,209",
      "failedChecks": [],
      "priorPrinted": "10,346",
      "groundingMismatch": false
    },
    {
      "note": "This row prints Total Assets.",
      "field": "totalAssets",
      "scale": 1000000,
      "value": 90038000000,
      "printed": "90,038",
      "rowIndex": 15,
      "rowLabel": "Total Assets",
      "priorValue": 92603000000,
      "agentPrinted": "90,038",
      "failedChecks": [],
      "priorPrinted": "92,603",
      "groundingMismatch": false
    },
    {
      "note": "This row is the Total Liabilities line, not liabilities and equity.",
      "field": "totalLiabilities",
      "scale": 1000000,
      "value": 71533000000,
      "printed": "71,533",
      "rowIndex": 25,
      "rowLabel": "Total Liabilities",
      "priorValue": 76215000000,
      "agentPrinted": "71,533",
      "failedChecks": [],
      "priorPrinted": "76,215",
      "groundingMismatch": false
    },
    {
      "note": "This is BMS shareholders’ equity attributable to the company, excluding noncontrolling interest.",
      "field": "totalEquity",
      "scale": 1000000,
      "value": 18473000000,
      "printed": "18,473",
      "rowIndex": 35,
      "rowLabel": "Total BMS Shareholders’ Equity",
      "priorValue": 16335000000,
      "agentPrinted": "18,473",
      "failedChecks": [],
      "priorPrinted": "16,335",
      "groundingMismatch": false
    }
  ],
  "statement": "balance",
  "tableIndex": 84,
  "priorColumn": 1,
  "currentColumn": 0
}
  5. 4reconciler (code)0.00s
    null
    [
  {
    "name": "balance_identity",
    "detail": "total assets equals total liabilities and equity",
    "fields": [
      "totalAssets"
    ],
    "passed": true,
    "skipped": false,
    "statement": "balance"
  },
  {
    "name": "totalEquity_attribution",
    "detail": "totalEquity excludes noncontrolling interests",
    "fields": [
      "totalEquity"
    ],
    "passed": true,
    "skipped": false,
    "statement": "balance"
  },
  {
    "name": "netIncome_before_preferred",
    "detail": "net income is not the after-preferred-dividends line",
    "fields": [
      "netIncome"
    ],
    "passed": true,
    "skipped": false,
    "statement": "income"
  },
  {
    "name": "epsDiluted_total",
    "detail": "diluted EPS is for total net income",
    "fields": [
      "epsDiluted"
    ],
    "passed": true,
    "skipped": false,
    "statement": "income"
  },
  {
    "name": "netIncome_attribution",
    "detail": "netIncome excludes noncontrolling interests",
    "fields": [
      "netIncome"
    ],
    "passed": true,
    "skipped": false,
    "statement": "income"
  },
  {
    "name": "cash_flow_tie",
    "detail": "missing a section total or no net change in cash line",
    "fields": [
      "operatingCashFlow",
      "investingCashFlow",
      "financingCashFlow"
    ],
    "passed": true,
    "skipped": true,
    "statement": "cashflow"
  }
]
  6. 5MD&A claims agent1.07s · 1359 tokens · $0.0001
    null
    []

Income statement

table #82 · current period is figure column 1
0Year Ended December 31,
1202520242023
2Net product sales46,75646,77843,778
3Alliance and other revenues1,4381,5221,228
4Total Revenues← Total revenue48,19448,30045,006
5Cost of products sold(a)13,93613,96810,693
6Selling, general and administrative7,2678,4147,772
7Research and development9,95111,1599,299
8Acquired IPRD3,72113,373913
9Amortization of acquired intangible assets3,3178,8729,047
10Other (income)/expense, net674893(1,158)
11Total Expenses38,86656,67936,566
12Earnings/(Loss) before income taxes9,328(8,379)8,440
13Income tax provision2,272554400
14Net earnings/(loss)7,055(8,933)8,040
15Noncontrolling Interest21515
16Net earnings/(loss) attributable to BMS← Net income attributable to the company7,054(8,948)8,025
17Earnings/(Loss) per common share:
18Basic3.47(4.41)3.88
19Diluted← Diluted EPS3.46(4.41)3.86

Balance sheet

table #84 · current period is figure column 1
0December 31,
1ASSETS20252024
2Current assets:
3Cash and cash equivalents← Cash and cash equivalents10,20910,346
4Marketable debt securities464513
5Receivables11,41410,747
6Inventories2,6902,557
7Other current assets4,6135,617
8Total Current assets29,39029,780
9Property, plant and equipment7,5437,136
10Goodwill21,75421,719
11Other intangible assets19,10323,307
12Deferred income taxes5,3784,236
13Marketable debt securities396320
14Other non-current assets6,4746,105
15Total Assets← Total assets90,03892,603
16LIABILITIES
17Current liabilities:
18Short-term debt obligations2,2612,046
19Accounts payable3,5753,602
20Other current liabilities17,58118,126
21Total Current liabilities23,41723,774
22Deferred income taxes222369
23Long-term debt42,85047,603
24Other non-current liabilities5,0434,469
25Total Liabilities← Total liabilities71,53376,215
26Commitments and Contingencies (Note 20)
27EQUITY
28Bristol-Myers Squibb Company Shareholders’ Equity:
29Preferred stock, $2 convertible series, par value $1 per share: Authorized 10 million shares; issued and outstanding 2,510 in 2025 and 2,868 in 2024, liquidation value of $50 per share--
30Common stock, par value of $0.10 per share: Authorized 4.5 billion shares; 2.9 billion issued in 2025 and 2024292292
31Capital in excess of par value of stock46,38746,024
32Accumulated other comprehensive loss(1,524)(1,238)
33Retained earnings16,89614,912
34Less cost of treasury stock - 887 million common shares in 2025 and 894 million common shares in 2024(43,579)(43,655)
35Total BMS Shareholders’ Equity← Total shareholders' equity attributable to the company18,47316,335
36Noncontrolling interest3353
37Total Equity18,50616,388
38Total Liabilities and Equity90,03892,603

Cash flow statement

table #85 · current period is figure column 1
0Year Ended December 31,
1202520242023
2Cash Flows From Operating Activities:
3Net earnings/(loss)7,055(8,933)8,040
4Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:
5Depreciation and amortization, net4,0119,6009,760
6Deferred income taxes(965)(2,089)(3,288)
7Stock-based compensation553507518
8Impairment charges1,0982,963255
9Divestiture gains and royalties(1,165)(1,119)(884)
10Acquired IPRD3,72113,373913
11Equity investment (gains)/losses, net(280)(16)160
12Contingent consideration fair value adjustments351--
13Other adjustments23294300
14Changes in operating assets and liabilities:
15Receivables(295)264(995)
16Inventories(184)(486)(751)
17Accounts payable(2)184198
18Rebates and discounts(441)1,484904
19Income taxes payable(4)(1,260)(603)
20Other471624(667)
21Net cash provided by operating activities← Net cash from operating activities14,15615,19013,860
22Cash Flows From Investing Activities:
23Sale and maturities of marketable debt securities1,9751,122733
24Purchase of marketable debt securities(2,000)(769)(1,774)
25Proceeds from sales of equity investments77265215
26Capital expenditures(1,311)(1,248)(1,209)
27Divestiture and other proceeds1,0711,099909
28Acquisition and other payments, net of cash acquired(3,944)(21,821)(1,169)
29Net cash provided by/(used in) investing activities← Net cash from investing activities(4,132)(21,352)(2,295)
30Cash Flows From Financing Activities:
31Proceeds from issuance of short-term debt obligations-2,987-
32Repayments of short-term debt obligations-(3,000)-
33Other short-term financing obligations, net2599(120)
34Proceeds from issuance of long-term debt5,74012,8834,455
35Repayments of long-term debt(10,940)(2,873)(3,879)
36Repurchase of common stock--(5,155)
37Dividends(5,045)(4,863)(4,744)
38Stock option proceeds and other, net(128)(106)27
39Net cash provided by/(used in) financing activities← Net cash from financing activities(10,348)5,127(9,416)
40Effect of exchange rates on cash, cash equivalents and restricted cash195(137)45
41Increase/(decrease) in cash, cash equivalents and restricted cash(129)(1,172)2,194
42Cash, cash equivalents and restricted cash at beginning of period10,34711,5199,325
43Cash, cash equivalents and restricted cash at end of period10,21810,34711,519